QQ客服 官方微博 反馈留言

	Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival
	Zhang Ying[1]; Ji Yajie[2]; Li Jianwei[3]; Lei Li[4]; Wu Siyu[5]; Zuo Wenjia[6]; Jia Xiaoqing[7]; Wang Yujie[8]; Mo Miao[9]; Zhang Na[10]
刊名	Breast cancer research and treatment
	2018
卷号	168页码:679-686
关键词	Breast cancer ER-positive GnRHa Ovarian preservation Premenopausal
ISSN号	1573-7217
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2181509
专题	上海大学
作者单位	1.Department of Breast Surgery, Fudan University Shanghai Cancer Center, 270 Dongan Road, Xuhui, 200032, Shanghai, People's Republic of China. 2.Department of Breast Surgery, Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Xuhui, Shanghai, People's Republic of China. 3.Department of Breast Surgery, Calmete Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China. 4.Department of Oncology, Shanghai Medical College, Fudan University, 138 Yi Xue Yuan Road, Xuhui, 200032, Shanghai, People's Republic of China. 5.Department of Medical Oncology, Shanghai Fengxian District Central Hospital, Fengxian, Shanghai, People's Republic of China.
推荐引用方式 GB/T 7714	Zhang Ying[1],Ji Yajie[2],Li Jianwei[3],et al. Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival[J]. Breast cancer research and treatment,2018,168:679-686.
APA	Zhang Ying[1].,Ji Yajie[2].,Li Jianwei[3].,Lei Li[4].,Wu Siyu[5].,...&Liu Guangyu[14].(2018).Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.Breast cancer research and treatment,168,679-686.
MLA	Zhang Ying[1],et al."Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival".Breast cancer research and treatment 168(2018):679-686.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。